JMP
174 Case Studies
A JMP Case Study
Medytox, a Korean biopharmaceutical company known for BTX-A therapies, needed to strengthen its internal infrastructure and navigate a volatile, tightly regulated clinical trial environment as it prepared to expand into global markets. To support faster, compliant trial operations, Medytox adopted JMP Clinical from JMP for clinical trial analytics and reporting.
Using JMP Clinical, Medytox consolidated data exploration, cleaning, risk-based monitoring, and safety reporting in one streamlined platform. JMP helped reduce processing time, limit costly on-site reviews, improve data standardization and real-time monitoring, and better position Medytox to enter the global market as an international biopharmaceutical leader.
Joo Hwan Lee
Head of Clinical Development